# A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)

> **NCT05823948** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 51 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Icodec

## Key facts

- **NCT ID:** NCT05823948
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-11
- **Primary completion:** 2024-03-06
- **Final completion:** 2024-04-11
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05823948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05823948, "A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05823948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*